6 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DMEdiabetic macular edemaActive, not recruitingPhase 32026-10-02NCT07449936
An Observational Study of the Progression of Intermediate Age-Related Macular Degenerationage-related macular degeneration, eye disorder, macular degeneration, retinal degeneration, retinal disorderActive, not recruitingNot stated2026-09-16NCT05300724
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56wet macular degenerationActive, not recruitingPhase 32026-09-03NCT06668064
A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular DegenerationNeovascular Age-related Macular Degeneration (nAMD)Active, not recruitingPhase 42026-07-31NCT06795048
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degenerationeye disorder, macular degeneration, retinal degeneration, retinal disorder, wet macular degenerationActive, not recruitingPhase 32026-06-01NCT06864988
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degenerationeye disorder, macular degeneration, retinal degeneration, retinal disorder, wet macular degenerationRecruitingPhase 32026-04-16NCT07064759